1. Recombinant human hyaluronidase facilitated subcutaneous immunoglobulin treatment in pediatric patients with primary immunodeficiencies: long-term efficacy, safety and tolerability. (October 2016) Authors: Wasserman, Richard L; Melamed, Isaac; Kobrynski, Lisa; Puck, Jennifer; Gupta, Sudhir; Doralt, Jennifer; Sharkhawy, Marlies; Engl, Werner; Leibl, Heinz; Gelmont, David; Yel, Leman Journal: Immunotherapy Issue: Volume 8:Number 10(2016:Oct.) Page Start: 1175 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Hyperimmune immunoglobulin for hospitalised patients with COVID-19 (ITAC): a double-blind, placebo-controlled, phase 3, randomised trial. Issue 10324 (5th February 2022) Authors: Polizzotto, Mark N.; Nordwall, Jacqueline; Babiker, Abdel G.; Phillips, Andrew; Vock, David M.; Eriobu, Nnakelu; Kwaghe, Vivian; Paredes, Roger; Mateu, Lourdes; Ramachandruni, Srikanth; Narang, Rajeev; Jain, Mamta K.; Lazarte, Susana M.; Baker, Jason V.; Frosch, Anne E.P.; Poulakou, Garyfallia; S... Journal: Lancet Issue: Volume 399:Issue 10324(2022) Page Start: 530 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Comparative biochemical efficacy analysis of an alpha1-proteinase inhibitor (Glassia®) in patients with alpha-1 antitrypsin deficiency. (June 2022) Authors: Li, Zhaoyang; Franke, Ryan M.; Morris, Denise; Yel, Leman Journal: Pulmonary pharmacology & therapeutics Issue: Volume 73/74(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Tolerability of subcutaneous immunoglobulin 20%, Ig20Gly, in pediatric patients with primary immunodeficiencies. (10th January 2019) Authors: Paris, Kenneth; Haddad, Elie; Borte, Michael; Brodszki, Nicholas; Dérfalvi, Beáta; Maródi, Laszlo; Hussain, Iftikhar; Darter, Amy; Engl, Werner; Leibl, Heinz; McCoy, Barbara; Yel, Leman Journal: Immunotherapy Issue: Volume 11:Number 5(2019) Page Start: 397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Improving patient tolerability in immunoglobulin treatment: focus on stabilizer effects. (June 2013) Authors: Sun, Adam; Teschner, Wolfgang; Yel, Leman Journal: Expert review of clinical immunology Issue: Volume 9:Number 6(2013) Page Start: 577 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Common variable immunodeficiency associated with microdeletion of chromosome 1q42.1‐q42.3 and inositol 1, 4, 5‐trisphosphate kinase B (ITPKB) deficiency. Issue 1 (22nd January 2016) Authors: Louis, Ankmalika G; Yel, Leman; Cao, Jia N; Agrawal, Sudhanshu; Gupta, Sudhir Journal: Clinical & translational immunology Issue: Volume 5:Issue 1 (2016) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗